InsidersTradesSigma
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (1 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
1
T+90 hit rate
33%
T+90 mean return
-21.0%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the detailed record of transactions filed by Cohen Neil Harris, Director. Director active across 1 company, notably Chemomab Therapeutics Ltd.. In total, 4 reports have been recorded. Split: 3 buys · 1 sell. Total volume traded: €32k. Activity tracked since 6 December 2021. The latest transaction was filed on 16 November 2022 (Cession). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Cohen Neil Harris
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations4 total
2,409 shares@ US$2.0010.4% of flowAmerican Depositary SharesSEC:0001178913-22-004100:0
2,000 shares@ US$3.190.051% mcap15.2% of flowAmerican Depositary SharesSEC:0001178913-22-002093:0
Canonical exit: 16 Aug 2022 (T+90)
2,000 shares@ US$4.200.065% mcap19.2% of flowAmerican Depositary SharesSEC:0001178913-22-001117:0
Canonical exit: 12 Jun 2022 (T+90)
2,000 shares@ US$7.430.11% mcap32.8% of flowAmerican Depositary SharesSEC:0001178913-21-003807:0
Canonical exit: 6 Mar 2022 (T+90)
4 of 4 declarations
About Cohen Neil Harris
Neil Harris Cohen is a Director of Chemomab Therapeutics Ltd. In this role, he participates in the governance of the company and strategic decision-making. His experience in the biopharmaceutical sector is an asset for the organization.
